Stocks

Wall Street Zen Downgrades Merck & Co., Inc. to Hold Rating

Guavy AI Editorial Team Published September 12, 2026

Instruments

MRK

Merck & Co., Inc. (NYSE:MRK) shares experienced a change in rating from investment analysts at Wall Street Zen, who downgraded the company from a 'buy' to a 'hold' rating in a recent report.

The downgrade was part of a broader analysis that included several other research firms weighing in on MRK. Royal Bank Of Canada lowered Merck & Co., Inc. from an 'outperform' rating to a 'sector perform' rating and upped their price target for the company from $142.00 to $150.00.

Morgan Stanley upgraded Merck & Co., Inc. from an 'equal weight' rating to an 'overweight' rating and raised their price objective for the stock from $116.00 to $179.00. Barclays lifted their target price on Merck & Co., Inc. from $140.00 to $150.00 and gave the company an 'overweight' rating.

Seventeen analysts have rated the stock with a Buy rating, while eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of 'Moderate Buy' and an average target price of $151.32.

Wall Street Zen Downgrades Merck & Co., Inc. to Hold Rating

Dow Jones Futures Tumble Under Pressure from Surging Yields and $100 Oil

AbbVie Stock Traded at 71.5 PE Ratio Raises Valuation Concerns

Canada's AI Agent Market Explodes with 26x Pricing Gap